£199.19

SKU HMG Category

HMG, or human menopausal gonadotropin, is an HMG peptide preparation used in research focused on reproductive hormone signaling. It contains a defined combination of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activity, which allows researchers to study pituitary–gonadal communication and gonadotropin-driven pathways under controlled laboratory conditions. Because the HMG peptide mimics aspects of natural endocrine stimulation, scientists can explore how FSH and LH influence cellular responses in isolated models.

Researchers value HMG for its role in experiments that investigate gametogenic regulation, steroidogenic signaling, and hormonal feedback mechanisms. It supports detailed studies on reproductive biology where precise activation of gonadal receptors is required. Additionally, the HMG peptide provides a direct comparison model between isolated gonadotropins and combined bioactivity profiles, helping clarify synergistic and timing-dependent signaling effects.

Laboratories often choose the HMG peptide for:

  • Studying LH and FSH receptor activation in vitro

  • Mapping hormone-regulated steroidogenic pathways

  • Exploring feedback loops within the reproductive endocrine axis

  • Comparing dual-activity gonadotropins with single-hormone analogues

Because HMG delivers predictable and measurable hormonal activity, it supports reproducible mechanistic research and reliable dose–response assessments. Its well-established functional profile suits experiments requiring consistent endocrine stimulation and clearly defined biological outputs.

Our HMG peptide is supplied as a high-purity laboratory reagent intended only for qualified scientific professionals. It is not approved for clinical, therapeutic, diagnostic, or veterinary use. All handling must comply with institutional safety procedures and regulatory requirements for experimental hormone materials.

For research use only. Not for human consumption.

COA Request

GET 10% OFF

Recieve product and research updates through our newsletter